QUILLICHEW ER Trademark

Trademark Overview

On Thursday, November 12, 2015, a trademark application was filed for QUILLICHEW ER with the United States Patent and Trademark Office. The USPTO has given the QUILLICHEW ER trademark a serial number of 86817633. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 3, 2023. This trademark is owned by NextWave Pharmaceuticals, Inc.. The QUILLICHEW ER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
quillichew er

General Information

Serial Number86817633
Word MarkQUILLICHEW ER
Filing DateThursday, November 12, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 3, 2023
Registration Number5120845
Registration DateTuesday, January 10, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
Disclaimer with Predetermined Text"ER"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2015
Primary Code005
First Use Anywhere DateMonday, April 18, 2016
First Use In Commerce DateMonday, April 18, 2016

Trademark Owner History

Party NameNextWave Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameNextWave Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameNextWave Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 17, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, January 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 10, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, December 7, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 2, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 9, 2016USE AMENDMENT FILED
Monday, November 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 9, 2016TEAS STATEMENT OF USE RECEIVED
Saturday, October 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2016SOU EXTENSION 1 GRANTED
Thursday, October 27, 2016SOU EXTENSION 1 FILED
Thursday, October 27, 2016TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 4, 2016ASSIGNED TO EXAMINER
Tuesday, November 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 16, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

quillichew treatment preparations pharmaceutical deficit disorder attention hyperactivity system central nervous